The British Society for Immunology, working through our Connect Immune Research partnership, is excited to be part of an innovative new grant call, which brings £1.3 million of new investment into autoimmune research.
The Lorna and Yuti Chernajovsky Biomedical Research Foundation and Connect Immune Research have partnered together to launch a new joint grant call, ‘Targeting shared mechanisms in immune-mediated inflammatory diseases.’ Applications are now open to this exciting new scheme which will provide up to £100,000 for 12 months to fund ‘pilot’ grants aimed at quickly developing proof of principle for potential new treatments for multiple immune-mediated inflammatory conditions by targeting pathways common in autoimmunity.
We’re looking for applications that:
- Target biological pathways that are relevant to multiple autoimmune or immune mediated inflammatory conditions
- Are innovative with high-quality science
- Have the potential to generate long term impact on quality of life for people currently living with autoimmune or immune-mediated conditions
- Are in the translational space
- Integrate collaboration and complementary expertise, connecting researchers with knowledge on different immune conditions/those from multiple institutions/those focused on different stages of the translational pathway.
- Contain meaningful patient and public involvement (PPI) at all stages including application development and research delivery
The application deadline is 16:00 BST on Wednesday 13 October 2021. Read the full call for applications on Versus Arthritis website.
Dr Doug Brown, Chief Executive of the British Society for Immunology, said:
“Immunology is a vital branch of medical science in which the UK leads the world with new discoveries. Connect Immune Research has joined forces with the Lorna and Yuti Chernajovsky Biomedical Research Foundation to develop this innovative new funding scheme that prioritises a collaborative, integrated approach to autoimmune research. By building on the UK’s existing strength in autoimmune research, we aim to bring together the best brains in immunology to study different autoimmune diseases together, driving forward our understanding of the underlying biological mechanisms and developing new treatments, which will ultimately transform the lives of people living with these conditions.”
Dr Lorna Chernajovsky, co-founder and trustee of the Lorna and Yuti Chernajovsky Biomedical Research Foundation, said:
“At the Chernajovsky Foundation, our aim is to fund innovative, high-quality translational research to bring about the development of new targeted biomedical therapies to improve health. Autoimmunity encompasses a variety of conditions that potentially are driven by similar biological mechanisms. By encouraging collaboration between researchers from across the spectrum of autoimmune disease, there are substantial knowledge gains to be made with the potential of significantly improving treatments for a range of conditions.
“The Chernajovsky Foundation is delighted to partner with Connect Immune Research on this exciting new grant call. We want to encourage applications targeting biological pathways that are relevant to multiple immune-mediated inflammatory conditions and which prioritise collaboration. By championing proposals that have the potential to advance towards clinical studies, we aim to provide new impetus to research and innovation into autoimmunity, ultimately improving the lives of people living with these conditions.”
On completion, the most promising projects will be invited to apply for follow-on funding, which may include funding for developing new methodologies or clinical trial designs potentially using repurposed current therapeutics.
Find out more
- You can view the full grant call and submit applications via the Versus Arthritis website.
- Please contact email@example.com for any enquiries about the grant scheme.
- Read the press release on this announcement here
The Lorna and Yuti Chernajovsky Biomedical Research Foundation was set up in 2019 to improve public health by providing grants to support high-quality biomedical research into the development of new targeted biomedical therapies.
Connect Immune Research is a partnership of charities who are dedicated to tackling autoimmune conditions. Members include the type 1 diabetes charity JDRF, Versus Arthritis, MS Society, British Society for Immunology, Alopecia UK, Coeliac UK, Psoriasis and Psoriatic Arthritis Alliance and Bowel Research UK.